Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

New approaches to the treatment of frontotemporal lobar degeneration.

Vossel KA, Miller BL.

Curr Opin Neurol. 2008 Dec;21(6):708-16. doi: 10.1097/WCO.0b013e328318444d. Review.

2.

Frontotemporal lobar degeneration: diversity of FTLD lesions.

Seilhean D, Bielle F, Plu I, Duyckaerts C.

Rev Neurol (Paris). 2013 Oct;169(10):786-92. doi: 10.1016/j.neurol.2013.07.015. Epub 2013 Sep 12. Review.

PMID:
24035575
3.

Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Bigio EH.

J Neuropathol Exp Neurol. 2008 Jul;67(7):635-48. doi: 10.1097/NEN.0b013e31817d751c. Review.

4.

Progranulin and frontotemporal lobar degeneration.

Pickering-Brown SM.

Acta Neuropathol. 2007 Jul;114(1):39-47. Epub 2007 Jun 16. Review.

PMID:
17572900
5.

Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.

van Swieten JC, Heutink P.

Lancet Neurol. 2008 Oct;7(10):965-74. doi: 10.1016/S1474-4422(08)70194-7. Epub 2008 Sep 2. Review.

PMID:
18771956
6.

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.

O'Brien JT, Burns A; BAP Dementia Consensus Group.

J Psychopharmacol. 2011 Aug;25(8):997-1019. doi: 10.1177/0269881110387547. Epub 2010 Nov 18.

PMID:
21088041
7.

The genetics of frontotemporal lobar degeneration.

Rademakers R, Hutton M.

Curr Neurol Neurosci Rep. 2007 Sep;7(5):434-42. Review.

PMID:
17764635
8.

The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments.

Mackenzie IR, Rademakers R.

Neurogenetics. 2007 Nov;8(4):237-48. Epub 2007 Sep 6. Review.

PMID:
17805587
9.

The heritability and genetics of frontotemporal lobar degeneration.

Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, Isaacs AM, Authier A, Ferrari R, Fox NC, Mackenzie IR, Warren JD, de Silva R, Holton J, Revesz T, Hardy J, Mead S, Rossor MN.

Neurology. 2009 Nov 3;73(18):1451-6. doi: 10.1212/WNL.0b013e3181bf997a.

10.

Frontotemporal Lobar Degeneration.

Premi E, Padovani A, Borroni B.

Adv Exp Med Biol. 2012;724:114-27. doi: 10.1007/978-1-4614-0653-2_9. Review.

PMID:
22411238
11.

Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.

Seltman RE, Matthews BR.

CNS Drugs. 2012 Oct 1;26(10):841-70. doi: 10.2165/11640070-000000000-00000. Review.

PMID:
22950490
12.

Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.

Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL 3rd, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DM; Consortium for Frontotemporal Lobar Degeneration.

Acta Neuropathol. 2007 Jul;114(1):5-22. Epub 2007 Jun 20.

13.

New insights into biological markers of frontotemporal lobar degeneration spectrum.

Borroni B, Alberici A, Archetti S, Magnani E, Di Luca M, Padovani A.

Curr Med Chem. 2010;17(10):1002-9. Review.

PMID:
20156164
14.

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review.

Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC.

J Neurol Neurosurg Psychiatry. 2011 May;82(5):476-86. doi: 10.1136/jnnp.2010.212225. Epub 2010 Oct 22. Review.

PMID:
20971753
15.

Pathology and genetics of frontotemporal lobar degeneration: an update.

Tolnay M, Frank S.

Clin Neuropathol. 2007 Jul-Aug;26(4):143-56. Review.

PMID:
17702495
16.

Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Rabinovici GD, Miller BL.

CNS Drugs. 2010 May;24(5):375-98. doi: 10.2165/11533100-000000000-00000. Review.

17.

Human genetics as a tool to identify progranulin regulators.

Nicholson AM, Finch NA, Rademakers R.

J Mol Neurosci. 2011 Nov;45(3):532-7. doi: 10.1007/s12031-011-9554-y. Epub 2011 May 28. Review.

18.

Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.

Rademakers R, Baker M, Gass J, Adamson J, Huey ED, Momeni P, Spina S, Coppola G, Karydas AM, Stewart H, Johnson N, Hsiung GY, Kelley B, Kuntz K, Steinbart E, Wood EM, Yu CE, Josephs K, Sorenson E, Womack KB, Weintraub S, Pickering-Brown SM, Schofield PR, Brooks WS, Van Deerlin VM, Snowden J, Clark CM, Kertesz A, Boylan K, Ghetti B, Neary D, Schellenberg GD, Beach TG, Mesulam M, Mann D, Grafman J, Mackenzie IR, Feldman H, Bird T, Petersen R, Knopman D, Boeve B, Geschwind DH, Miller B, Wszolek Z, Lippa C, Bigio EH, Dickson D, Graff-Radford N, Hutton M.

Lancet Neurol. 2007 Oct;6(10):857-68. Erratum in: Lancet Neurol. 2007 Dec;6(12):1037.

PMID:
17826340
19.

Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.

Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AM, Varma A, Neary D, Mann DM.

Brain. 2006 Nov;129(Pt 11):3091-102. Epub 2006 Sep 26.

PMID:
17003069
20.

TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.

Nicholson AM, Finch NA, Wojtas A, Baker MC, Perkerson RB 3rd, Castanedes-Casey M, Rousseau L, Benussi L, Binetti G, Ghidoni R, Hsiung GY, Mackenzie IR, Finger E, Boeve BF, Ertekin-Taner N, Graff-Radford NR, Dickson DW, Rademakers R.

J Neurochem. 2013 Sep;126(6):781-91. doi: 10.1111/jnc.12329. Epub 2013 Jul 1.

Supplemental Content

Support Center